Insmed Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | 102.7 | 71.1 | 33.9 | 15.6 | 15.7 | 9.5 | 16.2 | 19.3 | 20.7 | 20.9 | 18.3 | 18.5 | 17.1 | 13.9 | 10.7 | 10.7 | 10.8 | 9.1 | 10.8 | 12.9 | 14.7 | 12.8 | 31.5 | 37.0 | 34.0 | 36.2 | 47.8 | 68.1 | 61.3 | 43.0 | 20.4 | |
| 4.1 | 5.3 | 8.9 | 12.8 | 4.8 | 6.6 | 4.0 | 4.9 | 5.3 | 4.8 | 15.7 | 5.9 | 5.2 | 8.2 | 6.9 | 6.6 | 9.1 | 12.3 | 17.4 | 5.9 | 6.4 | 7.9 | 23.3 | 53.3 | – | 30.2 | – | – | – | – | – | 267.0 | 26.2 | 43.3 | 139.2 | 15.2 | 32.2 | 50.3 | 50.0 | 30.6 | |
| – | – | – | – | – | – | – | – | – | 84.5 | 68.3 | 29.6 | 13.7 | 14.6 | 9.0 | 14.5 | 18.0 | 19.7 | 20.7 | 16.1 | 16.9 | 16.4 | 15.3 | 12.3 | 12.3 | 11.1 | 9.7 | 12.8 | 15.3 | 17.0 | 14.6 | 31.4 | 38.5 | 35.5 | 38.1 | 46.0 | 68.6 | 61.4 | 43.0 | 20.4 | |
| -13.4% | -18.5% | -14.6% | -15.4% | -8.4% | -6.8% | -11.5% | -12.1% | -16.0% | -27.0% | -12.3% | -14.8% | -19.7% | -13.7% | -19.2% | -8.4% | -6.6% | -6.6% | -8.4% | -10.8% | -11.0% | -11.5% | -12.5% | -15.9% | -14.9% | -15.5% | -19.4% | -16.4% | -14.5% | -12.2% | -14.6% | -5.7% | -5.0% | -5.7% | -5.7% | -4.6% | -3.0% | -2.7% | -2.7% | -3.6% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | -564.4% | -64.2% | 42.2% | 82.2% | 82.3% | 81.2% | 79.5% | 77.6% | 75.7% | 75.4% | 75.3% | 76.0% | 76.6% | 76.9% | 76.5% | 77.1% | 77.5% | 78.0% | 78.9% | 78.6% | 78.5% | 78.1% | 77.6% | 77.2% | 76.4% | 76.5% | 75.7% | 76.5% | 79.7% | 81.6% | 83.3% | |
| – | – | – | – | – | – | – | – | – | -3,124.9% | -989.7% | -491.6% | -274.3% | -172.4% | -149.3% | -133.0% | -129.1% | -161.3% | -172.1% | -189.4% | -213.3% | -199.0% | -189.3% | -172.2% | -167.2% | -186.4% | -200.3% | -246.0% | -243.2% | -232.5% | -224.1% | -231.4% | -240.9% | -241.5% | -257.4% | -252.4% | -258.9% | -194.0% | -137.7% | -71.9% | |
| – | – | – | – | – | – | – | – | – | -3,297.2% | -1,039.5% | -518.5% | -291.2% | -186.4% | -162.8% | -147.5% | -145.1% | -178.9% | -190.4% | -219.7% | -244.0% | -230.6% | -217.3% | -188.0% | -179.4% | -196.3% | -212.3% | -258.2% | -257.7% | -245.6% | -236.7% | -244.3% | -252.0% | -251.2% | -265.9% | -259.8% | -264.8% | -210.5% | -144.4% | -76.9% | |
| – | – | – | – | – | – | – | – | – | -2,773.7% | -873.6% | -502.6% | -307.9% | -214.6% | -182.0% | -135.9% | -127.6% | -137.6% | -175.8% | -197.0% | -203.5% | -196.6% | -172.8% | -169.2% | -160.1% | -167.2% | -176.0% | -176.5% | -186.7% | -180.1% | -186.5% | -179.7% | -185.5% | -194.1% | -207.1% | -218.2% | -202.7% | -164.5% | -116.1% | -73.6% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -63.9% | -114.1% | -148.1% | -225.6% | -46.4% | -53.4% | -51.5% | -68.9% | -102.3% | -155.7% | -228.9% | -89.7% | -96.3% | -97.2% | -119.3% | -59.7% | -68.6% | -106.6% | -158.4% | -70.6% | -84.0% | -105.9% | -365.1% | -940.2% | – | -547.5% | – | – | – | – | – | -2,067.8% | -178.8% | -320.2% | -1,021.9% | -82.8% | -125.2% | -172.8% | -167.9% | -115.6% | |
| -50.3% | -74.1% | -89.8% | -113.6% | -38.7% | -41.7% | -28.9% | -35.3% | -45.1% | -53.6% | -55.4% | -39.9% | -38.4% | -34.3% | -36.4% | -27.3% | -29.1% | -36.9% | -46.1% | -30.5% | -32.3% | -35.0% | -37.9% | -39.5% | -43.7% | -29.1% | -36.0% | -48.4% | -54.6% | -56.4% | -64.4% | -44.3% | -42.1% | -45.1% | -56.2% | -41.7% | -50.1% | -56.4% | -57.0% | -41.6% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -166 | -53 | -71 | 19 | -320 | -270 | -81 | -20 | -256 | -179 | -90 | -266 | -193 | -139 | -76 | -287 | -227 | -164 | -41 | -372 | -282 | -140 | 277 | 373 | 376 | 59 | 172 | 534 | 669 | 687 | 578 | -63 | 508 | 565 | 712 | -735 | 217 | 50 | -26 | 8.6 | |
| 78.7% | 64.9% | 60.6% | 50.4% | 83.2% | 78.1% | 56.2% | 51.2% | 44.1% | 34.4% | 24.2% | 44.4% | 39.8% | 35.3% | 30.6% | 45.8% | 42.5% | 34.7% | 29.1% | 43.2% | 38.5% | 33.0% | 10.4% | 4.2% | -3.0% | 5.3% | -2.9% | -10.8% | -21.8% | -25.0% | -40.1% | 2.1% | 23.5% | 14.1% | 5.5% | 50.4% | 40.1% | 32.6% | 34.0% | 36.0% | |
| 0.2 | 0.7 | 0.5 | 1.3 | 0.3 | 0.3 | 1.4 | 1.7 | 1.1 | 1.5 | 2.3 | 0.9 | 1.1 | 1.3 | 1.7 | 0.9 | 1.0 | 1.3 | 1.8 | 1.0 | 1.1 | 1.4 | 6.6 | 17.8 | – | 12.9 | – | – | – | – | – | 30.5 | 2.0 | 3.9 | 11.2 | 0.4 | 0.6 | 0.8 | 0.8 | 0.7 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -2.25 | -2.85 | -2.90 | -3.03 | -3.00 | -2.52 | -2.92 | -3.33 | -3.87 | -4.21 | -4.25 | -3.91 | -3.28 | -2.84 | -2.75 | -2.50 | -2.41 | -2.87 | -3.10 | -3.42 | -3.62 | -3.67 | -3.68 | -3.48 | -3.60 | -3.63 | -4.01 | -5.06 | -5.06 | -5.18 | -5.03 | -5.19 | -4.98 | -5.10 | -5.60 | -5.46 | -5.60 | -5.98 | -5.49 | -4.03 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.41 | 0.75 | 1.13 | 1.53 | 1.69 | 1.70 | 1.66 | 1.61 | 1.63 | 1.56 | 1.48 | 1.59 | 1.69 | 1.85 | 2.01 | 1.85 | 1.89 | 1.96 | 1.97 | 2.11 | 2.13 | 2.12 | 1.97 | 2.03 | 2.11 | 2.10 | 2.11 | 2.84 | 3.80 | 5.23 | |
| 3.52 | 2.49 | 1.96 | 1.34 | 6.45 | 4.71 | 5.68 | 4.83 | 3.78 | 2.70 | 1.86 | 4.36 | 3.41 | 2.92 | 2.30 | 4.19 | 3.51 | 2.70 | 1.96 | 4.85 | 4.31 | 3.46 | 1.01 | 0.37 | -0.25 | 0.66 | -0.33 | -1.13 | -2.02 | -2.29 | -3.13 | 0.25 | 2.78 | 1.59 | 0.55 | 6.60 | 4.47 | 3.46 | 3.27 | 3.49 | |
| -1.94 | -2.44 | -2.55 | -2.65 | -2.62 | -2.12 | -2.59 | -2.86 | -3.22 | -3.54 | -3.58 | -3.79 | -3.47 | -3.27 | -3.07 | -2.31 | -2.12 | -2.21 | -2.86 | -3.07 | -3.02 | -3.13 | -2.93 | -3.13 | -3.21 | -3.09 | -3.32 | -3.46 | -3.67 | -3.79 | -3.96 | -3.82 | -3.66 | -3.94 | -4.36 | -4.59 | -4.29 | -4.67 | -4.42 | -3.85 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.